Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The Trump administration is touting $12 billion in federal savings in Medicare’s second year of drug price negotiations.

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...

Medicare beneficiaries will save on top Part D drugs in 2027, with price cuts up to 85% under the Inflation Reduction Act. Read more here.